✦ LIBER ✦

Efficacy and safety of bevacizumab in combination with docetaxel for the first-line treatment of elderly patients with locally recurrent or metastatic breast cancer: Results from AVADO

✍ Scribed by Xavier Pivot; Andreas Schneeweiss; Shailendra Verma; Christoph Thomssen; José Luis Passos-Coelho; Giovanni Benedetti; Eva Ciruelos; Roger von Moos; Hong-Tai Chang; Anja-Alexandra Duenne; David W. Miles

Book ID: 116430812
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 531 KB
Volume: 47
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2011.06.018

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Breast Avastin Trial: phase II study

The Breast Avastin Trial: phase II study of bevacizumab maintenance therapy after induction chemotherapy with docetaxel and capecitabine for the first-line treatment of patients with locally recurrent or metastatic breast cancer

✍ Bisagni, G.; Musolino, A.; Panebianco, M.; Matteis, A.; Nuzzo, F.; Ardizzoni, A. 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 256 KB

Safety results from a phase III study (T

Safety results from a phase III study (TURANDOT trial by CECOG) of first-line bevacizumab in combination with capecitabine or paclitaxel for HER-2-negative locally recurrent or metastatic breast cancer

✍ I. Lang; M.J. Inbar; Z. Kahán; R. Greil; S. Beslija; S.M. Stemmer; B. Kaufman; Z 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 302 KB

Phase II Multicenter Study of Docetaxel

Phase II Multicenter Study of Docetaxel and Bevacizumab With or Without Trastuzumab as First-Line Treatment for Patients With Metastatic Breast Cancer

✍ Schwartzberg, Lee S.; Badarinath, Suprith; Keaton, Mark R.; Childs, Barrett H. 📂 Article 📅 2014 🏛 CIG Media Group, LP. 🌐 English ⚖ 451 KB

2123 POSTER MO19391: an open-label safet

2123 POSTER MO19391: an open-label safety study of bevacizumab plus taxane monotherapy or in combination as first-line treatment of patients with locally recurrent or metastatic breast cancer (LR or MBC)

✍ I.E. Smith; L. Biganzoli; H. Cortes-Funes; F. Franke; Y. Mostafa Kamel; J.Y. Pie 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 57 KB

First-line bevacizumab in combination wi

First-line bevacizumab in combination with weekly paclitaxel for metastatic breast cancer: efficacy and safety results from a large, open-label, single-arm Japanese study

✍ Kenjiro Aogi; Norikazu Masuda; Shinji Ohno; Takashi Oda; Hiroji Iwata; Masahiro 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 308 KB

Efficacy and safety of bevacizumab in el

Efficacy and safety of bevacizumab in elderly patients with metastatic colorectal cancer: results from the Czech population-based registry

✍ Slavicek, Lubomir; Pavlik, Tomas; Tomasek, Jiri; Bortlicek, Zbynek; Buchler, Tom 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 209 KB